Document Detail

Newer antipsychotics and upcoming molecules for schizophrenia.
MedLine Citation:
PMID:  23545936     Owner:  NLM     Status:  Publisher    
BACKGROUND: The management of schizophrenia has seen significant strides over the last few decades, due to the increasing availability of a number of antipsychotics. Yet, the diminished efficacy in relation to the negative and cognitive symptoms of schizophrenia, and the disturbing adverse reactions associated with the current antipsychotics, reflect the need for better molecules targeting unexplored pathways. PURPOSE: To review the salient features of the recently approved antipsychotics; namely, iloperidone, asenapine, lurasidone and blonanserin. METHODS: We discuss the advantages, limitations and place in modern pharmacotherapy of each of these drugs. In addition, we briefly highlight the new targets that are being explored. RESULTS: Promising strategies include modulation of the glutamatergic and GABAergic pathways, as well as cholinergic systems. CONCLUSIONS: Although regulatory bodies have approved only a handful of antipsychotics in recent years, the wide spectrum of targets that are being explored could eventually bring out antipsychotics with improved efficacy and acceptability, as well as the potential to revolutionize psychiatric practice.
Melvin George; Radhika Amrutheshwar; Ravi Philip Rajkumar; Shivanand Kattimani; Steven Aibor Dkhar
Related Documents :
8016286 - The emergence of gender differences in depression during adolescence.
23233806 - Galantamine versus donepezil in chinese patients with alzheimer's disease: results from...
16865036 - Major depressive disorder in adolescence: the role of subthreshold symptoms.
23711226 - Utility of an effect size analysis for communicating treatment effectiveness: a case st...
24441996 - Cumulative trauma disorders among hand therapists.
21907546 - Improving cognitive treatments for delusions.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-4-2
Journal Detail:
Title:  European journal of clinical pharmacology     Volume:  -     ISSN:  1432-1041     ISO Abbreviation:  Eur. J. Clin. Pharmacol.     Publication Date:  2013 Apr 
Date Detail:
Created Date:  2013-4-2     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  1256165     Medline TA:  Eur J Clin Pharmacol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Cardiology, SRM Medical College Hospital & Research Centre, Chennai, India,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A status report on topical tazarotene in the management of acne vulgaris.
Next Document:  Extracellular calcium-sensing receptor/PTH knockout mice colons have increased Wnt/?-catenin signali...